ENTITY

Telomir Pharmaceuticals (TELO US)

14
Analysis
Health Care • United States
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.
more
•22 Feb 2025 00:00•Issuer-paid

TELO: Test Results Open Huge Market Potential

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Share
•19 Feb 2025 00:00•Issuer-paid

TELO: Exciting Test Results Bode Well for Future

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Share
•08 Jan 2025 01:00•Issuer-paid

TELO: Another Dose of Encouraging Tests

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Share
•04 Dec 2024 10:35•Issuer-paid

TELO: Another Potential Breakthrough

Preclinical tests showed that the company's signature therapy, Telomir-1, appeared to address insulin resistance and achieving reversal to near pre...

Share
x